We are delighted to announce our upcoming International Conference on Virology &Immunology invites you with regards to the aim on research, innovation, and scientific aspects. The conference is going to be held at Vancouver, Canada on June 15-16, 2022. The theme of the conference is “Exploring recent outbreaks, advanced technologies in treatment & research of infectious diseases”.
Virology 2022 is a global platform for Pathologists, virologist, industry professionals, marketing professionals and researchers, scientists, clinicians, academics, students, Liver oncologists, Surgeons, Research scholars and other healthcare professionals. The primary goal of the conference is to promote the latest advancements, research and developments, explore the challenges in Virology and Bacteriology related areas and share innovations, research, and ideas on pathology for a greater development and more effective treatments.
Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2015-2025.
FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.
Key Drivers: Virology Market
Key Restraints to Market Growth:
Maintaining the quality and safety standards of viral a controlling therapy has been a longstanding challenge, which is anticipated to hamper the market in the forecast period as well. Moreover, stringent approval processes for antiviral drugs is also foreseen to be a restraint to market growth. Another factor identified for affecting the market growth includes resistance toward and side effects of antiviral drugs for new treatment options.
Current Trends in the Virology Field:
In 2015, the virology industry was predominantly influenced by ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with better prospects in the near future.
Virologists are persistently investigating novel applications for viruses. Currently, an on-going research is experimenting on the exploitation of viruses for plant production, aiming at the efficient production of high quality, eco-friendly food.
Global Virology Market: Competitive Landscape:
By 2017 end, a few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. Following expiry of these blockbuster drugs, the market is estimated to discover a dynamic competitive landscape. The generic competition in the virology market will be at a high pace 2017 onward.
Apart from expiring drugs, the market also has some late stage pipeline drugs, including Inavir, Elvitegravir, Vicriviroc, Rilpivirine, and Rapiacta. These drugs are set to enter the global market, fostering the competition globally.
Regional Outlook: Global Virology Market:
North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.
Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.
Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.
Segment-wise Market Forecast:
Immunoprophylaxis therapy and antiviral drugs are the fastest-growing market segments in the estimated forecast period.
STDs, urinary tract infections, and respiratory tract infections are currently dominating compared to other application types in the global virology market.
On the basis of diagnosis tests, hepatitis B, hepatitis C, HIV, human papillomavirus (HPV), and other tests (influenza, ebola, and dengue) are estimated to attract the largest market shares globally.
Hospitals and laboratories projected to continue the most dominating end-use segments, accounting for almost 50% market share globally.
Key Players in the Global Virology Market:
The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.
Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer's, ebola, and HIV. The company also has many other candidates, which are currently under review.
Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and application.
Market Research and Market Trends of virology market
International Conference on Virology and Immunology helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in science and medicine.
We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company.
If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3million hits a month on our website, we have engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains. We maintain high quality and ethical standards of publication industry, which make us unique and better than the rest.
Our attendees can be your upcoming customers. If you sell research materials, recycling products, chemicals or relevant equipment or services, here is the opportunity to advertise in the website that can connect you to leading experts and science specialists worldwide.
Meetings International is a global leader in producing high quality conferences, meetings, workshops and symposia in all major fields of science, technology and medicine. Since its inception, Meetings International has been associated with national and international associations, corporations and high level individuals, dedicated to host world class conferences and events. Meetings International supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia, and industry.
Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
For further queries, connect our conference manager at email@example.com
You can also connect us via What Sapp: +44 1792 680 005
Google Analytics Metrics of Virology 2022
The visitor’s traffic is the benchmark for the success of conference and Virology 2022 is constantly attracting viewers across the world.
According to the Google Analytics, more than 100+ monthly audiences are visiting to our conference websites for submitting abstracts; brochure downloads registration, exhibition and sponsorship queries.
Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.
Google Analytics Metrics of Meetings International
437,380 + Users
1,606,987 + Page views
644,430 Sessions at the rate of 1.47 per user
Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers.
The promotion of the individual author contributions is taken care of and hence the authors enjoy the reputation among global audience. Meetings International values the contributions by the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving as well.
Learning In a New Space
New Tips & Tactics